Bangor Mail

Covid shield firm praises M-SParc


A COMPANY carrying out worldleadi­ng research into developing preventive and curative treatments for pandemic illnesses such as Covid-19 and Influenza using protein science has heaped praise on Menai Science Park on Anglesey.

Virustatic Ltd, who have used innovative protein technology to develop a snood – the Virustatic Shield – that offers up to 99% protection against respirator­y viruses, are tenants at Bangor University’s M-SParc, and have recently praised the benefits of being at the Park.

Virustatic’s Lucy Hope said: “The benefit of having our HQ at M-SParc is not only the state-of-the-art facilities, but also being part of a network of all that is supportive within innovation and developmen­t in Wales. You are never far away from other likeminded people, and it is easy to feed off the buzz of the environmen­t.

“The proximity and ease of access to the excellent academic links in Wales is also very beneficial. We are now a

BEACON project and we are working on an exciting venture with the BioComposi­tes Centre at Bangor University, which is important to us as a company with environmen­tal sustainabi­lity at the top of our agenda. Being at M-SParc has given us connection­s to organisati­ons such as Life Sciences Hub Wales, Accelerate, BIC Innovation and CALIN who are actively supporting us in our vision to do things differentl­y in response to new environmen­tal challenges.”

Following the successful launch of their Virustatic Shield, the company are working with Welsh institutio­ns to try and bring a preventati­ve and curative COVID and influenza inhaler, based on their protein science, through to clinical trials.

M-SParc MD Pryderi ap Rhisiart added: “We were pleased to be able to make the links to BioComposi­tes, via Bangor University. This is a great link to have, and a real benefit to our tenants that we are able to offer this type of support.”

Newspapers in English

Newspapers from United Kingdom